CHIEF EXECUTIVE OFFICER
Mon, Nov 18, 2024
Nov 18
10,554 shares @ $13.21
Decreased holdings by -8.90%
Net across this filing: +9.50% (+9,445 shares)
15th largest trade (out of 185)
Tax Sell-to-CoverPositive 90D History
Trade made by an officer
Automatic sale to cover taxes on a vest — not a discretionary trade
Net holdings across this filing: +9.5% (+9,445 shares)
64% win rate · +2.3% median edge vs SPY (14 trades, 90-day · small sample)
Price 11% below 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology